phosphorylcholine has been researched along with Hyaline Membrane Disease in 15 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A haemodynamically significant patent ductus arteriosus was clinically evident significantly earlier in babies who had received Survanta (mean age 1." | 1.29 | Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation. ( Malathi, I; Ng, KC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (86.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Majeed-Saidan, MA | 1 |
| al-Hifzi, I | 1 |
| Khan, M | 1 |
| Chatfield, SL | 1 |
| Kelly, EJ | 1 |
| Dear, PR | 1 |
| Cotton, RB | 1 |
| Olsson, T | 1 |
| Law, AB | 1 |
| Parker, RA | 1 |
| Lindstrom, DP | 1 |
| Silberberg, AR | 1 |
| Sundell, HW | 1 |
| Sandberg, K | 1 |
| Diwaker, K | 1 |
| Roberts, S | 1 |
| John, E | 1 |
| Malathi, I | 1 |
| Ng, KC | 1 |
| Todd, DA | 1 |
| Choukroun, ML | 1 |
| Fayon, M | 1 |
| Kays, C | 1 |
| Guénard, H | 1 |
| Galpérine, I | 1 |
| Demarquez, JL | 1 |
| Rossello, JD | 1 |
| Hayward, PE | 1 |
| Martell, M | 1 |
| Del Barco, M | 1 |
| Margotto, P | 1 |
| Grandzoto, J | 1 |
| Bastida, J | 1 |
| Peña, J | 1 |
| Villanueva, D | 1 |
| Iarŭkova, N | 1 |
| McMillan, DD | 1 |
| Singhal, N | 1 |
| Shukla, AK | 1 |
| Schürch, S | 1 |
| Helbich, TH | 1 |
| Popow, C | 1 |
| Dobner, M | 1 |
| Wunderbaldinger, P | 1 |
| Zekert, M | 1 |
| Herold, CJ | 1 |
| Frey, B | 1 |
| Keller, E | 1 |
| Losa, M | 1 |
| Tsvetkova, S | 1 |
| Chernookova, V | 1 |
| Efremova, R | 1 |
| Nedeva, N | 1 |
| Bogdanova, V | 1 |
| Narang, A | 1 |
| Kumar, P | 1 |
| Dutta, S | 1 |
| Kumar, R | 1 |
| Pfenninger, J | 1 |
| Aebi, C | 1 |
| Bachmann, D | 1 |
| Wagner, BP | 1 |
| Phibbs, RH | 1 |
| Ballard, RA | 1 |
| Clements, JA | 1 |
| Heilbron, DC | 1 |
| Phibbs, CS | 1 |
| Schlueter, MA | 1 |
| Sniderman, SH | 1 |
| Tooley, WH | 1 |
| Wakeley, A | 1 |
5 trials available for phosphorylcholine and Hyaline Membrane Disease
| Article | Year |
|---|---|
The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
Topics: Biological Products; Birth Weight; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Human | 1993 |
Respiratory mechanics before and after late artificial surfactant rescue.
Topics: Age Factors; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline M | 1995 |
Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
Topics: Birth Weight; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant Mo | 1997 |
Tracheal aspirate surface tension in babies with hyaline membrane disease: effects of synthetic surfactant replacement.
Topics: Double-Blind Method; Drug Combinations; Exudates and Transudates; Fatty Alcohols; Female; Humans; Hy | 1998 |
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
Topics: Administration, Inhalation; Birth Weight; Drug Combinations; Drug Evaluation; Fatty Alcohols; Follow | 1991 |
10 other studies available for phosphorylcholine and Hyaline Membrane Disease
| Article | Year |
|---|---|
Pulmonary haemorrhage in low-birthweight babies.
Topics: Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Hyaline Membrane Disease; Infant, Low Birth W | 1993 |
Adverse experiences in an Exosurf treated group.
Topics: Case-Control Studies; Drug Combinations; Fatty Alcohols; Humans; Hyaline Membrane Disease; Infant, N | 1994 |
Surfactant replacement therapy in neonates less than 32 weeks gestation: effect on neonatal intensive care resource utilization.
Topics: Case-Control Studies; Drug Combinations; Fatty Alcohols; Hospital Costs; Humans; Hyaline Membrane Di | 1993 |
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arte | 1995 |
[The effect of surfactant therapy on the oxygen treatment of premature infants with HMD].
Topics: Analysis of Variance; Biological Products; Combined Modality Therapy; Drug Combinations; Drug Evalua | 1998 |
New-born infants with severe hyaline membrane disease: radiological evaluation during high frequency oscillatory versus conventional ventilation.
Topics: Bronchopulmonary Dysplasia; Case-Control Studies; Drug Combinations; Fatty Alcohols; Female; High-Fr | 1998 |
Seizures after inadvertent umbilical venous infusion of synthetic surfactant (Exosurf): cause or coincidence?
Topics: Drug Combinations; Electroencephalography; Fatty Alcohols; Follow-Up Studies; Humans; Hyaline Membra | 1999 |
[Surfactant therapy in newborns with hyaline membrane disease].
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Hyaline Membrane Di | 2000 |
Surfactant therapy for hyaline membrane disease: the Chandigarh experience.
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; In | 2001 |
Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf)
Topics: Carbon Dioxide; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant, | 1992 |